HTG Molecular Diagnostics, Inc.
Symbol: HTGM
NASDAQ
0.48
USDMarknadspris idag
-0.0745
P/E-tal
-0.0008
PEG-kvot
1.06M
MRK Aktiekapital
- 0.00%
DIV Avkastning
{{företagets_namn}} (HTGM) Finansiella rapporter
Balansräkning
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 39.4 | 12.2 | 21.9 | 28.7 | |||||||||||
balance-sheet.row.short-term-investments | 15.23 | 0 | 12.3 | 6.3 | |||||||||||
balance-sheet.row.net-receivables | 4.77 | 1.4 | 2.1 | 1.6 | |||||||||||
balance-sheet.row.inventory | 5.21 | 0.9 | 2 | 1.5 | |||||||||||
balance-sheet.row.other-current-assets | 4.89 | 1.1 | 1.2 | 1.1 | |||||||||||
balance-sheet.row.total-current-assets | 54.94 | 15.7 | 27.2 | 32.9 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 6.65 | 1.6 | 2.5 | 2.2 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-non-current-assets | 2.88 | 0.5 | 0.8 | 0.1 | |||||||||||
balance-sheet.row.total-non-current-assets | 9.52 | 2.1 | 3.3 | 2.3 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 64.46 | 17.8 | 30.5 | 35.2 | |||||||||||
balance-sheet.row.account-payables | 4.08 | 1.2 | 1.6 | 1.3 | |||||||||||
balance-sheet.row.short-term-debt | 19.02 | 4.3 | 5.6 | 3.7 | |||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-debt-total | 4.92 | 0.5 | 6.1 | 8.9 | |||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 8.71 | 2.8 | 2.6 | 2 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 20.01 | 4.1 | 10.1 | 13.5 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 3.41 | 1 | 1.4 | 1.1 | |||||||||||
balance-sheet.row.total-liab | 51.81 | 12.4 | 20.1 | 20.7 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0.03 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.retained-earnings | -910.86 | -229.9 | -208.3 | -191.2 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.02 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 923.5 | 235.3 | 218.7 | 205.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 12.64 | 5.4 | 10.4 | 14.5 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 64.46 | 17.8 | 30.5 | 35.2 | |||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-equity | 12.64 | 5.4 | 10.4 | 14.5 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 64.46 | - | - | - | |||||||||||
Total Investments | 15.23 | 0 | 12.3 | 6.3 | |||||||||||
balance-sheet.row.total-debt | 23.94 | 4.8 | 11.7 | 12.6 | |||||||||||
balance-sheet.row.net-debt | -0.24 | -7.4 | 2.1 | -9.8 |
Kassaflödesanalys
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -20.15 | -21.6 | -17.1 | -20.9 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0.49 | 0.6 | 0.7 | 1.3 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -1.4 | 0.7 | |||||||||||
cash-flows.row.stock-based-compensation | 0.68 | 0.8 | 1.4 | 1.8 | |||||||||||
cash-flows.row.change-in-working-capital | -0.16 | -0.1 | -1 | -0.2 | |||||||||||
cash-flows.row.account-receivables | -0.38 | 0.7 | -0.8 | 1.6 | |||||||||||
cash-flows.row.inventory | 0.27 | 0.1 | -1.4 | -0.3 | |||||||||||
cash-flows.row.account-payables | -0.2 | -0.5 | 0.5 | 0 | |||||||||||
cash-flows.row.other-working-capital | 0.16 | -0.4 | 0.7 | -1.5 | |||||||||||
cash-flows.row.other-non-cash-items | 2.31 | 1.9 | 0.9 | 0.9 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -16.83 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.02 | 0 | -0.6 | -0.5 | |||||||||||
cash-flows.row.acquisitions-net | -99828.51 | 0 | -25018 | -72.5 | |||||||||||
cash-flows.row.purchases-of-investments | -11.15 | -7.6 | -18.6 | -12.5 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 14.52 | 19.9 | 12.6 | 31.6 | |||||||||||
cash-flows.row.other-investing-activites | 99828.64 | 0.1 | 25018 | 72.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 3.48 | 12.4 | -6.7 | 18.7 | |||||||||||
cash-flows.row.debt-repayment | -7.16 | -7.8 | -0.8 | -3.6 | |||||||||||
cash-flows.row.common-stock-issued | 2.8 | 1.4 | 10.7 | 7.5 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 6.09 | 15 | 0.5 | 5.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 1.73 | 8.6 | 10.4 | 9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | -11.62 | 2.6 | -12.8 | 11.5 | |||||||||||
cash-flows.row.cash-at-end-of-period | 24.18 | 12.2 | 9.6 | 22.4 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 35.79 | 9.6 | 22.4 | 10.9 | |||||||||||
cash-flows.row.operating-cash-flow | -16.83 | -18.4 | -16.5 | -16.3 | |||||||||||
cash-flows.row.capital-expenditure | -0.02 | 0 | -0.6 | -0.5 | |||||||||||
cash-flows.row.free-cash-flow | -16.85 | -18.4 | -17.2 | -16.7 |
Resultaträkning rad
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 6.21 | 6.4 | 8.9 | 8.5 | |||||||||||
income-statement-row.row.cost-of-revenue | 4.87 | 4.6 | 4.1 | 4 | |||||||||||
income-statement-row.row.gross-profit | 1.35 | 1.8 | 4.8 | 4.6 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 6.47 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | -0.24 | 0 | -1 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 20.94 | 22.6 | 22.6 | 24.1 | |||||||||||
income-statement-row.row.cost-and-expenses | 25.8 | 27.2 | 26.7 | 28.1 | |||||||||||
income-statement-row.row.interest-income | 0.19 | 0.1 | 0 | 0.3 | |||||||||||
income-statement-row.row.interest-expense | 0.75 | 0.9 | 1.1 | 1 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -0.55 | -0.8 | 0.7 | -1.3 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | -0.24 | 0 | -1 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -0.55 | -0.8 | 0.7 | -1.3 | |||||||||||
income-statement-row.row.interest-expense | 0.75 | 0.9 | 1.1 | 1 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0.55 | 0.7 | -1.7 | 1.6 | |||||||||||
income-statement-row.row.ebitda-caps | -19.29 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -19.59 | -20.8 | -17.8 | -19.6 | |||||||||||
income-statement-row.row.income-before-tax | -20.14 | -21.6 | -17.1 | -20.9 | |||||||||||
income-statement-row.row.income-tax-expense | 0.01 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.net-income | -20.15 | -21.6 | -17.1 | -20.9 |
Ofta ställda frågor
Vad är HTG Molecular Diagnostics, Inc. (HTGM) totala tillgångar?
HTG Molecular Diagnostics, Inc. (HTGM) totala tillgångar är 17777655.000.
Vad är företagets årliga omsättning?
Den årliga intäkten är 3471815.000.
Vad är företagets vinstmarginal?
Företagets vinstmarginal är 0.184.
Vad är företagets fria kassaflöde?
Fritt kassaflöde är -4.967.
Vad är företagets nettovinstmarginal?
Nettovinstmarginalen är -3.020.
Vad är företagets totala intäkter?
Totala intäkter är -2.946.
Vad är HTG Molecular Diagnostics, Inc. (HTGM) nettovinst (nettoinkomst)?
Nettovinst (nettoinkomst) är -21594476.000.
Vad är företagets totala skuldsättning?
Den totala skulden är 4833948.000.
Vad är rörelsens kostnader?
Rörelsens kostnader är 22623682.000.
Vad är företagets kassaflöde?
Företagets kassa är 2996409.000.